Our Vision : To become a leading specialty biopharmaceutical company in reproductive medicine. PregLem has IP rights on "first in class" compounds which are in clinical and pre-clinical development. At PregLem, we value collaborations with academic units innovating in reproductive medicine

PregLem SA ▫ Chemin des Aulx 12 ▫ 1228 Plan-les-Ouates, Geneva ▫ Switzerland
T +41 (0)22 884 03 40 ▫ F +41 (0) 22 884 03 49 ▫ info@preglem.com